Apr 17, 2018 by Motley Fool StaffA Blast From the Radio Past, Vol. 1: Reed HastingsWhat the Netflix CEO aspired to 15 years ago.
Apr 17, 2018 by Motley Fool StaffA Blast From the Radio Past, Vol. 1: Jeff BezosHere's what the Amazon founder perceived as his company’s chief aim.
Apr 16, 2018 by Motley Fool StaffNetflix, Inc. (NFLX) Q1 2018 Earnings Conference Call TranscriptNFLX earnings call for the period ending March 31, 2018.
Apr 16, 2018 by Motley Fool StaffA Blast From the Radio Past, Vol. 1David and Tom Gardner revisit some clips from their old radio shows.
Apr 16, 2018 by Motley Fool StaffDid Novartis Overpay for AveXis?$9.8 billion isn’t pocket change, but AveXis presents some huge potential opportunities down the road.
Apr 16, 2018 by Motley Fool StaffHow Did Biogen Miss AveXis?Biogen shareholders are probably not thrilled to see Novartis’ latest acquisition. What was Biogen thinking?
Apr 16, 2018 by Motley Fool StaffWhat Novartis Bought in AveXisNovartis’ $9.8 billion acquisition of AveXis signals some pretty exciting long-term focus in promising gene therapies.
Apr 16, 2018 by Motley Fool StaffWhat Incyte's Phase 3 Fail Means for Immuno-OncologyIncyte’s phase 3 Epacadostat trial wasn’t so hot, and stocks all across biotech are feeling the burn.
Apr 16, 2018 by Motley Fool StaffWhat's Next for Incyte?With a key pipeline drug nixed, Incyte has a few more question marks on the horizon than it did before.
Apr 16, 2018 by Motley Fool StaffThe Strange Tale of LongFinTrading in the fintech company's shares has been halted.
Apr 16, 2018 by Motley Fool StaffWalmart Makes a Bet on E-Commerce in IndiaThe retail giant is reportedly planning to buy a majority stake in Flipkart.
Apr 16, 2018 by Motley Fool StaffBad Guidance Sinks Bed Bath & BeyondThe troubled retailer’s stock hits a new low.
Apr 16, 2018 by Motley Fool StaffM&T Bank Corporation (MTB) Q1 2018 Earnings Conference Call TranscriptMTB earnings call for the period ending March 31, 2018.
Apr 16, 2018 by Motley Fool StaffBank of America Corporation (BAC) Q1 2018 Earnings Conference Call TranscriptBAC earnings call for the period ending March 31, 2018.
Apr 16, 2018 by Motley Fool StaffHas Estée Lauder Stock Flown Too Far, Too Fast?This multinational beauty powerhouse is trading at all-time highs, but the stock is not without its risks.
Apr 15, 2018 by Motley Fool StaffInfosys Ltd (INFY) Q4 2018 Earnings Conference Call TranscriptINFY earnings call for the period ending March 31, 2018.
Apr 15, 2018 by Motley Fool StaffWhy Estée Lauder Stock Is Gaining Momentum in 2018Accelerating top and bottom line growth has the market excited about this skincare giant.
Apr 14, 2018 by Motley Fool Staff2 Core Strengths Powering the Growth at Estée LauderThe multinational beauty powerhouse relies on smart distribution and acquisitions to enhance its bottom line.
Apr 13, 2018 by Motley Fool StaffWhat Happened With Incyte's IDO Inhibitor FlopInvestor confidence in epacadostat was through the roof, and the drug's phase 3 flop crushed the stock in a big way.
Apr 13, 2018 by Motley Fool StaffDelta Air Lines (DAL) Q1 2018 Earnings Conference Call TranscriptDAL earnings call for the period ending March 31, 2018.
